GSA Capital Partners’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-18,586
| Closed | -$289K | – | 1959 |
|
|
2021
Q4 | $289K | Buy |
18,586
+4,330
| +30% | +$67.3K | 0.04% | 960 |
|
|
2021
Q3 | $320K | Buy |
14,256
+3,204
| +29% | +$71.9K | 0.03% | 976 |
|
|
2021
Q2 | $252K | Buy |
+11,052
| New | +$252K | 0.03% | 1056 |
|
|
2021
Q1 | – | Sell |
-12,054
| Closed | -$333K | – | 1612 |
|
|
2020
Q4 | $333K | Sell |
12,054
-2,264
| -16% | -$62.5K | 0.05% | 682 |
|
|
2020
Q3 | $201K | Buy |
+14,318
| New | +$201K | 0.03% | 1011 |
|
|
2019
Q4 | – | Sell |
-25,685
| Closed | -$134K | – | 1820 |
|
|
2019
Q3 | $134K | Buy |
+25,685
| New | +$134K | 0.02% | 1245 |
|